Some patients want to take a holiday pause on weight-loss drugs. Here's what doctors say
The effects that a pause may have on your body may depend on why you're taking the medication in the first place.
24/7 Wall St2h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Novo Nordisk: Aggressive Dip-Buying Opportunity Has Finally Arrived
Novo Nordisk has an opportunity to expand indications on its weight loss drugs. Check out on what could be next for NVO stock ...
CT Medicaid accused of violating law by not covering weight loss drugs
One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...
We've Accepted Wegovy and Zepbound. The Next Phase Is Harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...
Will Novo Nordisk (NVO) Stock Recover To $145 Levels?
Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per share, nearly 40% below its peak level of over $145 seen in June of ...
NewsNation15h
West Virginia saw ‘incredible’ results with obesity drugs
( NewsNation) — The director of medical weight management at West Virginia University says a canceled pilot program that provided weight-loss drugs to state employees showed “incredible” results, with ...
dailymemphian17h
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
Yale doctor: Weight loss drugs could also help alcohol cravings
Weight loss drugs like Ozempic and Wegovy have seemingly taken over this year, curbing users appetites by making them feel ...
Everyday Health22h
FDA Says Shortages of GLP-1 Drugs Mounjaro and Zepbound Are Over
Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...
Big Take: Weight-Loss Drug Boom’s Prescription Problem
On today’s Big Take podcast, Bloomberg reporter Madison Muller joins host Sarah Holder to share what she’s learned about the ways telehealth can make it easier for people to get prescriptions that ...